|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
apoptosis
|
2 terms
|
 |
|
Biochemical function
|
cysteine-type peptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
7:1135-1143
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
The atomic-resolution structure of human caspase-8, a key activator of apoptosis.
|
|
W.Watt,
K.A.Koeplinger,
A.M.Mildner,
R.L.Heinrikson,
A.G.Tomasselli,
K.D.Watenpaugh.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Caspases are a family of cysteine proteases that have important
intracellular roles in inflammation and apoptosis. Caspase-8 activates
downstream caspases which are unable to carry out autocatalytic processing and
activation. Caspase-8 is designated as an initiator caspase and is believed to
sit at the apex of the Fas- or TNF-mediated apoptotic cascade. In view of this
role, the enzyme is an attractive target for the design of inhibitors aimed at
blocking the undesirable cell death associated with a range of degenerative
disorders. RESULTS: The structure of recombinant human caspase-8, covalently
modified with the inhibitor acetyl-Ile-Glu-Thr-Asp-aldehyde, has been determined
by X-ray crystallography to 1.2 A resolution. The asymmetric unit contains the
p18-p11 heterodimer; the biologically important molecule contains two dimers.
The overall fold is very similar to that of caspase-1 and caspase-3, but
significant differences exist in the substrate-binding region. The structure
answers questions about the enzyme-inhibitor complex that could not be explained
from earlier caspase structures solved at lower resolution. CONCLUSIONS: The
catalytic triad in caspase-8 comprises Cys360, His317 and the backbone carbonyl
oxygen atom of Arg258, which points towards the Nepsilon atom of His317. The
oxygen atom attached to the tetrahedral carbon in the thiohemiacetal group of
the inhibitor is hydrogen bonded to Ndelta of His317, and is not in a region
characteristic of a classical 'oxyanion hole'. The N-acetyl group of the
inhibitor is in the trans configuration. The caspase-8-inhibitor structure
provides the basis for understanding structure/function relationships in this
important initiator of the proteolytic cascade that leads to programmed cell
death.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 4.
Figure 4. Molecular surface representation of (a) caspase-8
and (b) caspase-3 generated using the program GRASP [37] and
viewed down the twofold axis. Areas of negative and positive
electrostatic potential are shown in red and blue, respectively.
The surface is viewed approximately parallel to the twofold
axis. The central cavities are outlined in black and the
tetrapeptide inhibitors and dithiane-diol molecules are shown as
stick models. (c) Close-up view of the electron density of the
dithiane-diol molecule located in the central cavity of
caspase-8.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1999,
7,
1135-1143)
copyright 1999.
|
|
| |
Figure was
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.Keller,
M.G.Grütter,
and
O.Zerbe
(2010).
Studies of the molecular mechanism of caspase-8 activation by solution NMR.
|
| |
Cell Death Differ, 17,
710-718.
|
 |
|
|
|
|
 |
P.Reszka,
R.Schulz,
K.Methling,
M.Lalk,
and
P.J.Bednarski
(2010).
Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
|
| |
ChemMedChem, 5,
103-117.
|
 |
|
|
|
|
 |
R.Sengupta,
T.R.Billiar,
V.E.Kagan,
and
D.A.Stoyanovsky
(2010).
Nitric oxide and thioredoxin type 1 modulate the activity of caspase 8 in HepG2 cells.
|
| |
Biochem Biophys Res Commun, 391,
1127-1130.
|
 |
|
|
|
|
 |
J.W.Yu,
P.D.Jeffrey,
and
Y.Shi
(2009).
Mechanism of procaspase-8 activation by c-FLIPL.
|
| |
Proc Natl Acad Sci U S A, 106,
8169-8174.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Keller,
J.Mares,
O.Zerbe,
and
M.G.Grütter
(2009).
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
|
| |
Structure, 17,
438-448.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.H.Jia,
J.Parodo,
A.Kapus,
O.D.Rotstein,
and
J.C.Marshall
(2008).
Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8.
|
| |
J Biol Chem, 283,
5402-5413.
|
 |
|
|
|
|
 |
S.Cursi,
A.Rufini,
V.Stagni,
I.Condò,
V.Matafora,
A.Bachi,
A.P.Bonifazi,
L.Coppola,
G.Superti-Furga,
R.Testi,
and
D.Barilà
(2006).
Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression.
|
| |
EMBO J, 25,
1895-1905.
|
 |
|
|
|
|
 |
Y.S.Hsiao,
G.Jogl,
and
L.Tong
(2006).
Crystal structures of murine carnitine acetyltransferase in ternary complexes with its substrates.
|
| |
J Biol Chem, 281,
28480-28487.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol, 21,
35-56.
|
 |
|
|
|
|
 |
C.M.Forsyth,
D.Lemongello,
D.J.LaCount,
P.D.Friesen,
and
A.J.Fisher
(2004).
Crystal structure of an invertebrate caspase.
|
| |
J Biol Chem, 279,
7001-7008.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.J.Chae,
H.R.Kim,
J.Bae,
S.U.Chae,
K.C.Ha,
and
S.W.Chae
(2004).
Signal transduction of the protective effect of insulin like growth factor-1 on adriamycin-induced apoptosis in cardiac muscle cells.
|
| |
Arch Pharm Res, 27,
324-333.
|
 |
|
|
|
|
 |
J.A.Hardy,
J.Lam,
J.T.Nguyen,
T.O'Brien,
and
J.A.Wells
(2004).
Discovery of an allosteric site in the caspases.
|
| |
Proc Natl Acad Sci U S A, 101,
12461-12466.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.J.Romanowski,
J.M.Scheer,
T.O'Brien,
and
R.S.McDowell
(2004).
Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate binding.
|
| |
Structure, 12,
1361-1371.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
and
Y.Shi
(2004).
Molecular mechanisms of caspase regulation during apoptosis.
|
| |
Nat Rev Mol Cell Biol, 5,
897-907.
|
 |
|
|
|
|
 |
X.Jiang,
and
X.Wang
(2004).
Cytochrome C-mediated apoptosis.
|
| |
Annu Rev Biochem, 73,
87.
|
 |
|
|
|
|
 |
A.Schweizer,
C.Briand,
and
M.G.Grutter
(2003).
Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
|
| |
J Biol Chem, 278,
42441-42447.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.W.Chang,
Z.Xing,
V.L.Capacio,
M.E.Peter,
and
X.Yang
(2003).
Interdimer processing mechanism of procaspase-8 activation.
|
| |
EMBO J, 22,
4132-4142.
|
 |
|
|
|
|
 |
K.M.Boatright,
M.Renatus,
F.L.Scott,
S.Sperandio,
H.Shin,
I.M.Pedersen,
J.E.Ricci,
W.A.Edris,
D.P.Sutherlin,
D.R.Green,
and
G.S.Salvesen
(2003).
A unified model for apical caspase activation.
|
| |
Mol Cell, 11,
529-541.
|
 |
|
|
|
|
 |
M.Bando,
M.Hasegawa,
Y.Tsuboi,
Y.Miyake,
M.Shiina,
M.Ito,
H.Handa,
K.Nagai,
and
T.Kataoka
(2003).
The mycotoxin penicillic acid inhibits Fas ligand-induced apoptosis by blocking self-processing of caspase-8 in death-inducing signaling complex.
|
| |
J Biol Chem, 278,
5786-5793.
|
 |
|
|
|
|
 |
S.Stoven,
N.Silverman,
A.Junell,
M.Hedengren-Olcott,
D.Erturk,
Y.Engstrom,
T.Maniatis,
and
D.Hultmark
(2003).
Caspase-mediated processing of the Drosophila NF-kappaB factor Relish.
|
| |
Proc Natl Acad Sci U S A, 100,
5991-5996.
|
 |
|
|
|
|
 |
X.Tao,
and
L.Tong
(2003).
Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease.
|
| |
J Biol Chem, 278,
31372-31379.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
O.Micheau,
M.Thome,
P.Schneider,
N.Holler,
J.Tschopp,
D.W.Nicholson,
C.Briand,
and
M.G.Grütter
(2002).
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
|
| |
J Biol Chem, 277,
45162-45171.
|
 |
|
|
|
|
 |
Y.Shi
(2002).
Mechanisms of caspase activation and inhibition during apoptosis.
|
| |
Mol Cell, 9,
459-470.
|
 |
|
|
|
|
 |
Y.T.Zhou,
U.J.Soh,
X.Shang,
G.R.Guy,
and
B.C.Low
(2002).
The BNIP-2 and Cdc42GAP homology/Sec14p-like domain of BNIP-Salpha is a novel apoptosis-inducing sequence.
|
| |
J Biol Chem, 277,
7483-7492.
|
 |
|
|
|
|
 |
J.C.Reed
(2001).
Apoptosis-regulating proteins as targets for drug discovery.
|
| |
Trends Mol Med, 7,
314-319.
|
 |
|
|
|
|
 |
J.Chai,
E.Shiozaki,
S.M.Srinivasula,
Q.Wu,
P.Datta,
E.S.Alnemri,
Y.Shi,
and
P.Dataa
(2001).
Structural basis of caspase-7 inhibition by XIAP.
|
| |
Cell, 104,
769-780.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Chai,
Q.Wu,
E.Shiozaki,
S.M.Srinivasula,
E.S.Alnemri,
and
Y.Shi
(2001).
Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.
|
| |
Cell, 107,
399-407.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Rotonda,
M.Garcia-Calvo,
H.G.Bull,
W.M.Geissler,
B.M.McKeever,
C.A.Willoughby,
N.A.Thornberry,
and
J.W.Becker
(2001).
The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
|
| |
Chem Biol, 8,
357-368.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
M.Renatus,
R.Schwarzenbacher,
Q.Zhou,
C.Sun,
S.W.Fesik,
R.C.Liddington,
and
G.S.Salvesen
(2001).
Structural basis for the inhibition of caspase-3 by XIAP.
|
| |
Cell, 104,
791-800.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
P.Fuentes-Prior,
M.Renatus,
N.Kairies,
S.Krapp,
R.Huber,
G.S.Salvesen,
and
W.Bode
(2001).
Structural basis for the activation of human procaspase-7.
|
| |
Proc Natl Acad Sci U S A, 98,
14790-14795.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
U.Sartorius,
I.Schmitz,
and
P.H.Krammer
(2001).
Molecular mechanisms of death-receptor-mediated apoptosis.
|
| |
Chembiochem, 2,
20-29.
|
 |
|
|
|
|
 |
Y.Huang,
Y.C.Park,
R.L.Rich,
D.Segal,
D.G.Myszka,
and
H.Wu
(2001).
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
|
| |
Cell, 104,
781-790.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Y.Jones
(2000).
The tumour necrosis factor receptor family: life or death choices.
|
| |
Curr Opin Struct Biol, 10,
644-648.
|
 |
|
|
|
|
 |
J.C.Reed,
and
K.J.Tomaselli
(2000).
Drug discovery opportunities from apoptosis research.
|
| |
Curr Opin Biotechnol, 11,
586-592.
|
 |
|
|
|
|
 |
M.G.Grütter
(2000).
Caspases: key players in programmed cell death.
|
| |
Curr Opin Struct Biol, 10,
649-655.
|
 |
|
|
|
|
 |
M.Renatus,
Q.Zhou,
H.R.Stennicke,
S.J.Snipas,
D.Turk,
L.A.Bankston,
R.C.Liddington,
and
G.S.Salvesen
(2000).
Crystal structure of the apoptotic suppressor CrmA in its cleaved form.
|
| |
Structure, 8,
789-797.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.W.Fesik
(2000).
Insights into programmed cell death through structural biology.
|
| |
Cell, 103,
273-282.
|
 |
|
|
|
|
 |
Y.Wei,
T.Fox,
S.P.Chambers,
J.Sintchak,
J.T.Coll,
J.M.Golec,
L.Swenson,
K.P.Wilson,
and
P.S.Charifson
(2000).
The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.
|
| |
Chem Biol, 7,
423-432.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.S.Salvesen
(1999).
Caspase 8: igniting the death machine.
|
| |
Structure, 7,
R225-R229.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|